Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

BACKGROUND: We have recently completed an evaluation of the safety and feasibility of intravenous delivery of autologous bone marrow in patients with progressive multiple sclerosis (MS). The possibility of repair was suggested by improvement in the neurophysiological secondary outcome measure seen i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rice, Claire M., Marks, David I., Ben-Shlomo, Yoav, Evangelou, Nikos, Morgan, Paul S., Metcalfe, Chris, Walsh, Peter, Kane, Nick M., Guttridge, Martin G., Miflin, Gail, Blackmore, Stuart, Sarkar, Pamela, Redondo, Juliana, Owen, Denise, Cottrell, David A., Wilkins, Alastair, Scolding, Neil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606493/
https://www.ncbi.nlm.nih.gov/pubmed/26467901
http://dx.doi.org/10.1186/s13063-015-0953-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606493/
https://www.ncbi.nlm.nih.gov/pubmed/26467901
http://dx.doi.org/10.1186/s13063-015-0953-1

Ejemplares similares